• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

破骨细胞、类风湿性关节炎与骨免疫学

Osteoclasts, rheumatoid arthritis, and osteoimmunology.

作者信息

Sato Kojiro, Takayanagi Hiroshi

机构信息

Department of Cell Signaling, Graduate School, Tokyo Medical and Dental University, Japan.

出版信息

Curr Opin Rheumatol. 2006 Jul;18(4):419-26. doi: 10.1097/01.bor.0000231912.24740.a5.

DOI:10.1097/01.bor.0000231912.24740.a5
PMID:16763464
Abstract

PURPOSE OF REVIEW

Osteoclasts are terminally differentiated cells of the monocyte/macrophage lineage that resorb bone matrix. Bone destruction in rheumatoid arthritis is mainly attributable to the abnormal activation of osteoclasts, and studies on activation of osteoclasts by the immune system have led to the new research field called osteoimmunology. This interdisciplinary field is very important to biologic research and to the treatment of diseases associated with the bone and immune systems.

RECENT FINDINGS

The T-cell-mediated regulation of osteoclast differentiation is dependent on cytokines and membrane-bound factors expressed by T cells. The cross-talk between receptor activator of nuclear factor-kappaB ligand and interferon-gamma has been shown to be crucial for the regulation of osteoclast formation in arthritic joints. Recent studies indicate that an increasing number of immunomodulatory factors are associated with the regulation of bone metabolism: nuclear factor of activated T cells c1 has been shown to be the key transcription factor for osteoclastogenesis, the activation of which requires calcium signaling induced by the immunoglobulin-like receptors.

SUMMARY

New findings in osteoimmunology will be instrumental in the development of strategies for research into the treatment of various diseases afflicting the skeletal and immune systems.

摘要

综述目的

破骨细胞是单核细胞/巨噬细胞谱系的终末分化细胞,可吸收骨基质。类风湿关节炎中的骨破坏主要归因于破骨细胞的异常激活,而关于免疫系统对破骨细胞激活的研究催生了名为骨免疫学的新研究领域。这个跨学科领域对于生物学研究以及与骨骼和免疫系统相关疾病的治疗都非常重要。

最新发现

T细胞介导的破骨细胞分化调节依赖于T细胞表达的细胞因子和膜结合因子。核因子κB受体活化因子配体与干扰素-γ之间的相互作用已被证明对关节炎关节中破骨细胞形成的调节至关重要。最近的研究表明,越来越多的免疫调节因子与骨代谢调节相关:活化T细胞核因子c1已被证明是破骨细胞生成的关键转录因子,其激活需要免疫球蛋白样受体诱导的钙信号。

总结

骨免疫学的新发现将有助于制定针对影响骨骼和免疫系统的各种疾病的治疗研究策略。

相似文献

1
Osteoclasts, rheumatoid arthritis, and osteoimmunology.破骨细胞、类风湿性关节炎与骨免疫学
Curr Opin Rheumatol. 2006 Jul;18(4):419-26. doi: 10.1097/01.bor.0000231912.24740.a5.
2
Inflammatory bone destruction and osteoimmunology.炎症性骨破坏与骨免疫学
J Periodontal Res. 2005 Aug;40(4):287-93. doi: 10.1111/j.1600-0765.2005.00814.x.
3
Osteoclasts in arthritis and Th17 cell development.关节炎和 Th17 细胞发育中的破骨细胞。
Int Immunopharmacol. 2011 May;11(5):543-8. doi: 10.1016/j.intimp.2010.11.010. Epub 2010 Nov 26.
4
The dynamic interplay between osteoclasts and the immune system.破骨细胞与免疫系统之间的动态相互作用。
Arch Biochem Biophys. 2008 May 15;473(2):166-71. doi: 10.1016/j.abb.2008.04.004. Epub 2008 Apr 8.
5
Interplay between interferon and other cytokine systems in bone metabolism.干扰素与其他细胞因子系统在骨代谢中的相互作用。
Immunol Rev. 2005 Dec;208:181-93. doi: 10.1111/j.0105-2896.2005.00337.x.
6
Osteoimmunology.骨免疫学
Int Arch Allergy Immunol. 2007;143(1):31-48. doi: 10.1159/000098223. Epub 2006 Dec 22.
7
The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis.破骨细胞从巨噬细胞分化的机制:T淋巴细胞在破骨细胞生成中的可能作用。
J Bone Miner Metab. 2003;21(6):337-43. doi: 10.1007/s00774-003-0439-1.
8
New immune connections in osteoclast formation.破骨细胞形成中的新免疫连接。
Ann N Y Acad Sci. 2010 Mar;1192:117-23. doi: 10.1111/j.1749-6632.2009.05303.x.
9
[Cross-talk between immune and skeletal systems].[免疫系统与骨骼系统之间的相互作用]
Nihon Rinsho. 2002 Dec;60(12):2287-95.
10
Osteoimmunology--the hidden immune regulation of bone.骨免疫学——骨骼隐藏的免疫调节
Autoimmun Rev. 2009 Jan;8(3):250-5. doi: 10.1016/j.autrev.2008.07.038. Epub 2008 Aug 21.

引用本文的文献

1
Bone Marrow Adipoq-lineage Progenitors: an Emerging Osteoclast Niche Cell Population.骨髓脂肪细胞系祖细胞:一种新兴的破骨细胞微环境细胞群体。
Curr Osteoporos Rep. 2025 Sep 12;23(1):37. doi: 10.1007/s11914-025-00933-2.
2
The protective effects of dietary resistant starch against post-antibiotic bone loss in meat ducks associated with the recovery of caecal microbiota dysbiosis.日粮抗性淀粉对肉鸭抗生素后骨质流失的保护作用与盲肠微生物群失调的恢复有关。
Poult Sci. 2025 May 1;104(8):105238. doi: 10.1016/j.psj.2025.105238.
3
Divergent Requirements for Glutathione Biosynthesis During Osteoclast Differentiation In Vitro and In Vivo.
破骨细胞体外和体内分化过程中谷胱甘肽生物合成的不同需求
Antioxidants (Basel). 2025 Feb 10;14(2):197. doi: 10.3390/antiox14020197.
4
Myeloid-specific deletion of autotaxin inhibits rheumatoid arthritis and osteoclastogenesis.自分泌运动因子的髓系特异性缺失可抑制类风湿性关节炎和破骨细胞生成。
Front Immunol. 2024 Dec 18;15:1481699. doi: 10.3389/fimmu.2024.1481699. eCollection 2024.
5
Cytoplasmic DNA and AIM2 inflammasome in RA: where they come from and where they go?细胞质 DNA 与 RA 中的 AIM2 炎性体:它们从何而来,又将去往何处?
Front Immunol. 2024 Oct 10;15:1343325. doi: 10.3389/fimmu.2024.1343325. eCollection 2024.
6
Glutaminolysis provides nucleotides and amino acids to regulate osteoclast differentiation in mice.谷氨酰胺分解代谢为破骨细胞分化提供核苷酸和氨基酸以进行调节。
EMBO Rep. 2024 Oct;25(10):4515-4541. doi: 10.1038/s44319-024-00255-x. Epub 2024 Sep 13.
7
Cell-specific gene networks and drivers in rheumatoid arthritis synovial tissues.类风湿关节炎滑膜组织中的细胞特异性基因网络和驱动因素。
Front Immunol. 2024 Aug 5;15:1428773. doi: 10.3389/fimmu.2024.1428773. eCollection 2024.
8
The miR-29-3p family suppresses inflammatory osteolysis.miR-29-3p 家族抑制炎症性骨溶解。
J Cell Physiol. 2024 Aug;239(8):e31299. doi: 10.1002/jcp.31299. Epub 2024 May 19.
9
Large-scale computational modelling of the M1 and M2 synovial macrophages in rheumatoid arthritis.类风湿关节炎中M1和M2滑膜巨噬细胞的大规模计算建模
NPJ Syst Biol Appl. 2024 Jan 26;10(1):10. doi: 10.1038/s41540-024-00337-5.
10
New Horizons: Translational Aspects of Osteomorphs.新视野:骨形态发生的转化方面。
J Clin Endocrinol Metab. 2024 Apr 19;109(5):e1373-e1378. doi: 10.1210/clinem/dgad711.